130 related articles for article (PubMed ID: 38627550)
1. HRQoL in patients receiving EV versus chemotherapy.
Masone MC
Nat Rev Urol; 2024 May; 21(5):257. PubMed ID: 38627550
[No Abstract] [Full Text] [Related]
2. Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme.
Osoba D; Brada M; Yung WK; Prados M
J Clin Oncol; 2000 Apr; 18(7):1481-91. PubMed ID: 10735896
[TBL] [Abstract][Full Text] [Related]
3. Dysgeusia and health-related quality of life of cancer patients receiving chemotherapy: A cross-sectional study.
Ponticelli E; Clari M; Frigerio S; De Clemente A; Bergese I; Scavino E; Bernardini A; Sacerdote C
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 28101929
[TBL] [Abstract][Full Text] [Related]
4. [Changes in symptom patterns and health-related quality of life of cancer patients before and after chemotherapy].
Chung HW; Chien LY; Huang SM; Tai CJ; Tai CJ
J Tradit Chin Med; 2016 Jun; 36(3):326-31. PubMed ID: 27468547
[TBL] [Abstract][Full Text] [Related]
5. Impact on Health-Related Quality of Life of Induction Chemotherapy Compared With Concurrent Cisplatin and Radiation Therapy in Patients With Head and Neck Cancer.
Adkins D; Ley J; Oppelt P; Gay HA; Daly M; Paniello RC; Jackson R; Pipkorn P; Rich J; Zevallos J; Trinkaus K; Thorstad W
Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e123-e131. PubMed ID: 31147146
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial.
Cortes J; Hudgens S; Twelves C; Perez EA; Awada A; Yelle L; McCutcheon S; Kaufman PA; Forsythe A; Velikova G
Breast Cancer Res Treat; 2015 Dec; 154(3):509-20. PubMed ID: 26567010
[TBL] [Abstract][Full Text] [Related]
7. Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles.
Sultan A; Choudhary V; Parganiha A
Chronobiol Int; 2017; 34(5):609-623. PubMed ID: 28276853
[TBL] [Abstract][Full Text] [Related]
8. Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa.
Patrick DL; Gagnon DD; Zagari MJ; Mathijs R; Sweetenham J;
Eur J Cancer; 2003 Feb; 39(3):335-45. PubMed ID: 12565986
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.
Friedlander M; Rau J; Lee CK; Meier W; Lesoin A; Kim JW; Poveda A; Buck M; Scambia G; Shimada M; Hilpert F; King MT; Debruyne P; Bologna A; Malander S; Monk BJ; Petru E; Calvert P; Herzog TJ; Barrett C; du Bois A
Ann Oncol; 2018 Mar; 29(3):737-743. PubMed ID: 29267856
[TBL] [Abstract][Full Text] [Related]
10. Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes.
Efficace F; Mandelli F; Avvisati G; Cottone F; Ferrara F; Di Bona E; Specchia G; Breccia M; Levis A; Sica S; Finizio O; Kropp MG; Fioritoni G; Cerqui E; Vignetti M; Amadori S; Schlenk RF; Platzbecker U; Lo-Coco F
J Clin Oncol; 2014 Oct; 32(30):3406-12. PubMed ID: 25245446
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy.
Baggott CR; Dodd M; Kennedy C; Marina N; Matthay KK; Cooper B; Miaskowski C
Support Care Cancer; 2011 Mar; 19(3):353-61. PubMed ID: 20157746
[TBL] [Abstract][Full Text] [Related]
12. Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial.
Saad F; Cella D; Basch E; Hadaschik BA; Mainwaring PN; Oudard S; Graff JN; McQuarrie K; Li S; Hudgens S; Lawson J; Lopez-Gitlitz A; Yu MK; Smith MR; Small EJ
Lancet Oncol; 2018 Oct; 19(10):1404-1416. PubMed ID: 30213449
[TBL] [Abstract][Full Text] [Related]
13. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.
Boyle FM; Smith IE; O'Shaughnessy J; Ejlertsen B; Buzdar AU; Fumoleau P; Gradishar W; Martin M; Moy B; Piccart-Gebhart M; Pritchard KI; Lindquist D; Amonkar M; Huang Y; Rappold E; Williams LS; Wang-Silvanto J; Kaneko T; Finkelstein DM; Goss PE;
Eur J Cancer; 2015 Apr; 51(6):685-96. PubMed ID: 25752740
[TBL] [Abstract][Full Text] [Related]
14. Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life.
Stöckelmaier L; Renovanz M; König J; Nickel K; Hickmann AK; Mayer-Steinacker R; Nadji-Ohl M; Ganslandt O; Bullinger L; Wirtz CR; Coburger J
World Neurosurg; 2017 Jun; 102():383-399. PubMed ID: 28288921
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial.
Cella D; Pickard AS; Duh MS; Guerin A; Mishagina N; Antràs L; Neary MP; McCann L; Hodge R; Sternberg CN
Eur J Cancer; 2012 Feb; 48(3):311-23. PubMed ID: 21689927
[TBL] [Abstract][Full Text] [Related]
16. Self-directed physical activity intervention in older adults undergoing adjuvant chemotherapy for colorectal cancer: Design of a randomized controlled trial.
Williams GR; Nyrop KA; Deal AM; Muss HB; Sanoff HK
Contemp Clin Trials; 2015 May; 42():90-7. PubMed ID: 25827253
[TBL] [Abstract][Full Text] [Related]
17. Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study.
Desramé J; Baize N; Anota A; Laribi K; Stefani L; Hjiej S; Nabirotchkina E; Zelek L; Choquet S
Cancer Treat Res Commun; 2023; 37():100781. PubMed ID: 38039763
[TBL] [Abstract][Full Text] [Related]
18. Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review.
Sommariva S; Pongiglione B; Tarricone R
Crit Rev Oncol Hematol; 2016 Mar; 99():13-36. PubMed ID: 26697988
[TBL] [Abstract][Full Text] [Related]
19. Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review.
Kristensen A; Vagnildhaug OM; Grønberg BH; Kaasa S; Laird B; Solheim TS
Crit Rev Oncol Hematol; 2016 Mar; 99():286-98. PubMed ID: 26819138
[TBL] [Abstract][Full Text] [Related]
20. Symptoms and Health-Related Quality of Life in Patients Receiving Cancer Therapy Matched to Genomic Profiles.
Williams K; Bergquist-Beringer S
Oncol Nurs Forum; 2018 Nov; 45(6):E125-E136. PubMed ID: 30339156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
